Treatment of Vulvovaginal Candidiasis with Vulval Itching in a Non-Pregnant Woman

Clinical scenario

This protocol covers the first-line management of acute symptomatic vulvovaginal candidiasis in a non-pregnant woman without a history of chronic or recurrent disease. Symptomatic patients require treatment, and multiple evidence-based options are available.

Presenting symptoms

Vulval itching is a hallmark complaint. Affected women frequently also report one or more of the following:

Vulval itching Vaginal redness Soreness Burning Dyspareunia Dysuria

Treatment goal

The aim is full resolution of symptoms — the patient becomes asymptomatic. The most efficient strategy reduces fungal burden to a level that achieves this clinical endpoint.

Treatment approach (overview — incomplete)

For mild-to-normal symptom severity, first-line treatment centres on topical imidazole derivatives applied locally. For more severe presentations, oral agents are also an option in non-pregnant women.

The complete regimen — specific agents, routes, durations, and clinical decision points — is available in the full structured protocol.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1111/myc.13248

In addition to itching, affected women often complain of vaginal redness, a feeling of soreness, burning, dyspareunia and dysuria.
In contrast, symptomatic patients require treatment, and there are numerous options to treat these patients.
Acute VVC can be treated locally with topical imidazole derivatives (ie clotrimazole, econazole, isoconazole, fenticonazole, miconazole) at the first manifestation.
Alternative treatment options for non-pregnant women are oral triazoles (ie fluconazole, itraconazole, posaconazole, voriconazole), polyenes (ie nystatin), and ciclopiroxolamine.
Local treatment with 500 mg clotrimazole as vaginal tablet or 10% vaginal cream was proven effective as single oral administration of 150 mg fluconazole.
If VVC affects the vulva outside of the introitus vaginae or inguinal region, an antifungal cream (e.g., clotrimazole) is recommended twice daily for one week.
The most efficient treatment strategy should not aim to eradicate all fungi from the lower genital tract but to reduce their number so that the patient is asymptomatic.

View source ↗